Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Asset Writedowns and Impairment (2016 - 2026)

Cryo Cell International's Asset Writedowns and Impairment history spans 17 years, with the latest figure at $213341.0 for Q1 2026.

  • Quarterly results put Asset Writedowns and Impairment at $213341.0 for Q1 2026, down 21.34% from a year ago — trailing twelve months through Feb 2026 was $4.3 million (up 1380.81% YoY), and the annual figure for FY2024 was $308000.0, down 64.55%.
  • Asset Writedowns and Impairment for Q1 2026 was $213341.0 at Cryo Cell International, down from $4.4 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $4.4 million in Q4 2025 to a low of -$634405.0 in Q4 2022.
  • The 5-year median for Asset Writedowns and Impairment is $225294.0 (2022), against an average of $666740.0.
  • The sharpest move saw Asset Writedowns and Impairment soared 1533.03% in 2022, then crashed 1509.6% in 2025.
  • Year by year, Asset Writedowns and Impairment stood at -$634405.0 in 2022, then soared by 689.08% to $3.7 million in 2023, then plummeted by 99.49% to $19240.0 in 2024, then soared by 22555.06% to $4.4 million in 2025, then crashed by 95.11% to $213341.0 in 2026.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods came in at $213341.0, $4.4 million, and -$271207.0 for Q1 2026, Q4 2025, and Q2 2025 respectively.